We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
SWISS LAW AND TAX
Services
Intellectual Property
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Meet our team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
In the VISCHER Innovation Lab, we not only work in the field of law, we also develop our solutions ourselves as far as possible from a technical point of view.
VISCHER Legal Innovation Lab
Red Ink
Careers
Ikerian, a healthcare software platform company that organizes multimodal data at-scale, closes the first tranche of USD 8m Series B Financing to advance its AI platform alongside.
ImmunOs Therapeutics AG, in Schlieren, a biopharmaceutical company developing first-in-class therapeutics for the treatment of cancer and autoimmune diseases based on its unique immune system modulating technology platform, closed a Series C financing round.
HAYA Therapeutics SA, a Swiss biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics, announced a multi-year agreement with Eli Lilly and Company to apply HAYA’s advanced RNA-guided regulatory genome platform to support preclinical drug discovery efforts in obesity and related metabolic conditions.
Genedata AG (“Genedata”), a leading provider of software solutions for biopharmaceutical research and development, has been acquired by Danaher Corporation (NYSE: DHR) (“Danaher”), a leading global innovator in life sciences and diagnostics.
Mininavident AG, in Liestal, developer and manufacturer of the world’s smallest dynamic navigation system for dental implant placement, was acquired by the Straumann Group, a global leader in tooth replacement, orthodontic solutions and adjacent dental technologies.
Memo Therapeutics AG, a late-stage biotech company developing a best-in-class BKV-neutralizing anti-body for BKV infection in kidney transplantation, raised CHF 20m as part of an extension of its series C financing round.
Proteomedix AG, ein privates Schweizer Diagnostikunternehmen im kommerziellen Stadium, und Blue Water Biotech, Inc.
Evorest AG is a fintech start-up that specializes in the digital management of rental deposits. As a novelty, tenants will be able to invest their rental deposits digitally in low-cost funds instead of keeping their money tied up...
SWIMRUN AG, the organizer of major swimrun events, has acquired a majority stake in Swimrun USA Inc., which owns all rights to the Ödyssey Swimrun Series in the United States. Following the transaction, SWIMRUN will be the market...
T3 Pharmaceuticals AG, a biotechnology company with its headquarter in Allschwil, Switzerland has been acquired by Boehringer Ingelheim, a leading family-owned, research-driven biopharmaceutical company based in Ingelheim, Germany...
Displaying results 1 to 10 out of 138
